Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer ; volume:18 ; number:1 ; day:20 ; month:5 ; year:2020 ; pages:1-12 ; date:12.2020
World journal of surgical oncology ; 18, Heft 1 (20.5.2020), 1-12, 12.2020
- Creator
-
Nogués, Ana
Gallardo-Vara, Eunate
Zafra, Mª. Paz
Mate, Paloma
Marijuan, Jose Luis
Alonso, Alfredo
Botella, Luisa Mª
Prieto, Mª. Isabel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-020-01871-2
- URN
-
urn:nbn:de:101:1-2020072423015883788395
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nogués, Ana
- Gallardo-Vara, Eunate
- Zafra, Mª. Paz
- Mate, Paloma
- Marijuan, Jose Luis
- Alonso, Alfredo
- Botella, Luisa Mª
- Prieto, Mª. Isabel
- SpringerLink (Online service)
Other Objects (12)
Anti-angiogenic alternatives to VEGF blockade
Localization and functional study of VEGF receptors in normal and adenomatous pituitary : evidence for a non-angiogenic role of VEGF
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A
Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma
Dissemination of colorectal cancer information among Hispanic patients and their social network
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Diabetic angiopathy and angiogenic defects
Anti-angiogenic alternatives to VEGF blockade
Localization and functional study of VEGF receptors in normal and adenomatous pituitary : evidence for a non-angiogenic role of VEGF
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A
Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma
Dissemination of colorectal cancer information among Hispanic patients and their social network
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer
Diabetic angiopathy and angiogenic defects
Anti-angiogenic alternatives to VEGF blockade
Localization and functional study of VEGF receptors in normal and adenomatous pituitary : evidence for a non-angiogenic role of VEGF
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer
The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A
Expression of integrin genes and proteins in progression and dissemination of colorectal adenocarcinoma
Dissemination of colorectal cancer information among Hispanic patients and their social network
Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling
Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Identification of the angiogenic gene signature induced by EGF and hypoxia in colorectal cancer